Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Century Therapeutics (IPSC) Return on Sales (2022 - 2025)

Historic Return on Sales for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to 0.23%.

  • Century Therapeutics' Return on Sales rose 392400.0% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year increase of 481400.0%. This contributed to the annual value of 19.21% for FY2024, which is 419400.0% up from last year.
  • Century Therapeutics' Return on Sales amounted to 0.23% in Q3 2025, which was up 392400.0% from 0.2% recorded in Q2 2025.
  • In the past 5 years, Century Therapeutics' Return on Sales ranged from a high of 0.7% in Q1 2025 and a low of 336.27% during Q2 2023
  • For the 4-year period, Century Therapeutics' Return on Sales averaged around 65.07%, with its median value being 32.82% (2024).
  • Per our database at Business Quant, Century Therapeutics' Return on Sales tumbled by -3140800bps in 2023 and then soared by 2958000bps in 2024.
  • Century Therapeutics' Return on Sales (Quarter) stood at 60.81% in 2022, then plummeted by -142bps to 147.02% in 2023, then skyrocketed by 94bps to 8.64% in 2024, then soared by 97bps to 0.23% in 2025.
  • Its Return on Sales was 0.23% in Q3 2025, compared to 0.2% in Q2 2025 and 0.7% in Q1 2025.